Stockscreener 앱 받기
6.30
2.48%
-0.16
전일 마감가:
$6.46
열려 있는:
$6.48
하루 거래량:
168.37K
Relative Volume:
0.73
시가총액:
$255.09M
수익:
$68.68M
순이익/손실:
$-60.84M
주가수익비율:
-3.913
EPS:
-1.61
순현금흐름:
$-38.42M
1주 성능:
+1.61%
1개월 성능:
+4.48%
6개월 성능:
-21.93%
1년 성능:
-43.19%
1일 변동 폭
$6.26
$6.66
1주일 범위
$6.12
$7.09
52주 변동 폭
$5.46
$14.84
풀몬스 Stock (LUNG) Company Profile
명칭
Pulmonx Corp
전화
650-364-0400
주소
700 CHESAPEAKE DRIVE, REDWOOD CITY
LUNG을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LUNG
Pulmonx Corp
|
6.30 | 255.09M | 68.68M | -60.84M | -38.42M | -1.61 |
|
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
|
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
|
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
|
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
|
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
풀몬스 Stock (LUNG) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-04 | 개시 | Lake Street | Buy |
| 2024-02-23 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-09-05 | 개시 | Craig Hallum | Buy |
| 2023-02-27 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-01-03 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-12-12 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-07-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-03-02 | 재개 | BofA Securities | Neutral |
| 2021-12-08 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2021-04-01 | 개시 | Citigroup | Buy |
| 2021-03-25 | 개시 | Piper Sandler | Neutral |
| 2021-03-10 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2021-01-04 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-10-26 | 개시 | BofA Securities | Buy |
| 2020-10-26 | 개시 | Canaccord Genuity | Buy |
| 2020-10-26 | 개시 | Morgan Stanley | Equal-Weight |
| 2020-10-26 | 개시 | Stifel | Buy |
| 2020-10-26 | 개시 | Wells Fargo | Equal Weight |
모두보기
풀몬스 주식(LUNG)의 최신 뉴스
Pulmonx (NASDAQ:LUNG) vs. Fractyl Health (NASDAQ:GUTS) Head-To-Head Review - Defense World
Pulmonx director French sells $132,600 in stock - Investing.com
Millrace Asset Group Inc. Purchases Shares of 167,725 Pulmonx Co. (NASDAQ:LUNG) - MarketBeat
Does Pulmonx (LUNG) Have the Potential to Rally 117.74% as Wall Street Analysts Expect? - Yahoo Finance
Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference - Yahoo Finance
Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers - Yahoo Finance
Endobronchial Valve System Market Explosive Growth - openPR
FMR LLC Bolsters Stake in Pulmonx Corp - GuruFocus.com
Morgan Stanley's Strategic Reduction in Pulmonx Corp Holdings - GuruFocus.com
Pulmonx to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum - Yahoo Finance
Wall Street Analysts Predict an 89.61% Upside in Pulmonx (LUNG): Here's What You Should Know - Yahoo Finance
Here's What Analysts Are Forecasting For Pulmonx Corporation (NASDAQ:LUNG) After Its Third-Quarter Results - Yahoo Finance UK
Pulmonx Third Quarter 2024 Earnings: EPS Beats Expectations - Yahoo Finance
Pulmonx Corporation (NASDAQ:LUNG) Q3 2024 Earnings Call Transcript - Insider Monkey
Pulmonx Corp (LUNG) Q3 2024 Earnings Call Highlights: Strong Rev - GuruFocus.com
Earnings call: Pulmonx reports solid growth and strategic advances in Q3 - Investing.com UK
Pulmonx Corp (LUNG) Q3 2024 Earnings: Revenue Hits $20.4M, EPS a - GuruFocus.com
Pulmonx Corp (LUNG) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic ... - Yahoo Finance UK
Pulmonx Corp (LUNG) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic ... By GuruFocus - Investing.com Canada
Pulmonx Corporation (LUNG) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance
Pulmonx earnings beat by $0.81, revenue topped estimates - Investing.com
Pulmonx Reports Third Quarter 2024 Financial Results - Yahoo Finance
Pulmonx Co. (NASDAQ:LUNG) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
nVerses Capital LLC Buys Shares of 3,100 Pulmonx Co. (NASDAQ:LUNG) - Defense World
Pulmonx (LUNG) Set to Announce Quarterly Earnings on Wednesday - MarketBeat
Pulmonx director sells $130,399 in common stock By Investing.com - Investing.com South Africa
Pulmonx director sells $130,399 in common stock - Investing.com India
Pulmonx to Report Third Quarter 2024 Financial Results on October 30, 2024 - Yahoo Finance
Millennium Management LLC Lowers Stock Position in Pulmonx Co. (NASDAQ:LUNG) - MarketBeat
Point72 Asia Singapore Pte. Ltd. Makes New Investment in Pulmonx Co. (NASDAQ:LUNG) - Defense World
Squarepoint Ops LLC Acquires 104,432 Shares of Pulmonx Co. (NASDAQ:LUNG) - MarketBeat
Pulmonx Co. (NASDAQ:LUNG) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Point72 Asset Management L.P. Sells 2,474,183 Shares of Pulmonx Co. (NASDAQ:LUNG) - MarketBeat
Point72 Asia Singapore Pte. Ltd. Takes $37,000 Position in Pulmonx Co. (NASDAQ:LUNG) - Defense World
Phunware (NASDAQ:PHUN) Stock Price Up 4.2% - Defense World
PulteGroup Inc [PHM] Insider FOLLIARD THOMAS J sells 19,000 Shares – Latest News - Knox Daily
Urban Outfitters, Inc. (NASDAQ:URBN) Shares Sold by Shapiro Capital Management LLC - Defense World
Market Recap: Trupanion Inc (TRUP)’s Positive Momentum, Closing at 42.80 - The Dwinnex
Bank of New York Mellon Corp Purchases 17,740 Shares of Pulmonx Co. (NASDAQ:LUNG) - Defense World
PulteGroup, Inc. (NYSE:PHM) Shares Sold by MQS Management LLC - Defense World
Trupanion (NASDAQ:TRUP) Given New $45.00 Price Target at Northland Securities - Defense World
Texas Permanent School Fund Corp Has $1.08 Million Stake in Trupanion, Inc. (NASDAQ:TRUP) - Defense World
Intech Investment Management LLC Purchases 133,283 Shares of PulteGroup, Inc. (NYSE:PHM) - Defense World
Waterloo Capital L.P. Sells 223 Shares of PulteGroup, Inc. (NYSE:PHM) - Defense World
Trupanion (NASDAQ:TRUP) Shares Gap Up on Analyst Upgrade - MarketBeat
Pulmonx director French Glendon E. III sells $161,800 in company stock - Investing.com Australia
Glendon E. French III Sells 20,000 Shares of Pulmonx Co. (NASDAQ:LUNG) Stock - Defense World
Pulmonx Co. (NASDAQ:LUNG) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World
Pulmonx Announces Presentation of Clinical Data from the AeriSeal® CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024 - Yahoo Finance
Pulmonx executive sells over $30,000 in company stock - Investing.com India
Pulmonx corp general counsel sells over $38k in company stock - Investing.com
풀몬스 (LUNG) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.65%
자본화:
|
볼륨(24시간):